SnagRx advertises medicine-inclusive compounded rates, Noom combines several plan pathways with digital tools, and Trimi offers monthly and longer terms. The shared GLP-1 label does not identify one common contract.
Use the public offer details below to prepare questions. A licensed clinician should decide which treatment is appropriate; a listing order or sale price is not a clinical comparison.
Make the prices comparable
Compare SnagRx’s month-to-month and final-sale terms with Noom’s exact quarterly renewal and Trimi’s annual up-front amount or monthly rate. A cheaper monthly equivalent can require more cash today and a longer commitment.
What each provider publicly describes
SnagRx: The fresh homepage advertised semaglutide at $69 per month and tirzepatide at $119. Confirm the current rate, treatment quantity, and any subscription length before purchase. A stated flat price should be checked against the exact term in the order.
Noom Med: The pricing page describes several introductory offers followed by higher ongoing rates, frequently billed quarterly. Its branded-medication pathway advertises $39 to begin, then $129 per month after month one, billed quarterly, with medication charged separately. Some compounded pathways describe care, medication, and digital tools together.
Trimi: Trimi’s detailed page lists semaglutide at $99 per month on a twelve-month plan billed $1,188 up front, or $175 month to month. Tirzepatide is listed at $125 per month on an annual plan billed $1,500 up front, or $235 month to month. Confirm current plan terms and checkout amounts.
Questions before choosing
Ask each service for the actual ingredients, route, amount supplied, dispensing pharmacy, first payment, ongoing payment, and commitment. Keep branded and compounded products distinct.
Confirm the clinical practice, how to contact the prescriber, refill assessment, and cancellation deadline. Marketing about results or convenience does not establish which provider is clinically superior.
Continue your comparison
Compare the GLP-1 programs, read the CoreAge Rx review, and use the program table to prepare questions about the complete offer.
Sources & offer details
Public information retrieved on October 1, 2026. Provider statements describe the advertised offer; they do not independently establish treatment outcomes.